Distal technologies and type 1 diabetes management
Duke DC, Barry S, Wagner DV, et al.
Lancet Diabetes Endocrinol 2018;6(2):143-56
Leggi
Breaking news
Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
Thomas NJ, Jones SE, Weedon MN, et al.
Lancet Diabetes Endocrinol 2018;6(2):122-9
Leggi
Antihyperglycemic and Metabolic Effects of Ranolazine in Patients with Diabetes Mellitus
Gilbert BW, Sherard M, Little L, et al.
Am J Cardiol 2018;121(4):509-12
Leggi
Genetics and biobanks converge to resolve a vexing knowledge gap in diabetes
Florez JC
Lancet Diabetes Endocrinol 2018;6(2):87-9
Leggi
Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c, weight and hypoglycaemic event incidence
McEwan P, Bennett H, Bolin K, et al.
Diabe Med. Pub. online: 27 January 2018
Leggi
Diabetes and adiposity: a heavy load for cancer
Park Y, Colditz GA
Lancet Diabetes Endocrinol 20186(2):82-3
Leggi
From Diabetes Care to Diabetes Cure—The Integration of Systems Biology, eHealth, and Behavioral Change
van Ommen B, Wopereis S, van Empelen P, et al.
Front Endocrinol. Pub. on 22 January 2018
Leggi
Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
Pearson-Stuttard J, Zhou B, Kontis V, et al.
Lancet Diabetes Endocrinol 2018;6(2):95-104
Leggi
Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
De Rosa S, Arcidiacono B, Chiefari E, et al.
Front Endocrinol. Pub. online 17 January 2018
Leggi
Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)
Hendriks SH, Schrijnders D, van Hateren KJJ, et al.
BMJ Open 2018;8:e018859
Leggi